Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dengue virus NS5 protein is the largest and most conserved nonstructural protein encoded by the dengue virus genome. The N-terminal domain of NS5 possesses methyltransferase (MTase) activity, specifically functioning as a 2'-O-methyltransferase, which is essential for capping the viral RNA genome. This enzyme catalyzes methylation reactions required for forming the type I cap structure at the 5' end of viral RNA, protecting it from degradation, facilitating efficient translation, and evading host innate immune responses. It also interacts with host proteins to antagonize interferon signaling pathways. As a result of its crucial role in viral replication and immune evasion, the MTase activity of NS5 is an attractive target for antiviral drug development.
Inhibition of methyltransferase activity, blocking cap formation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dengue Virus NS5 2'-O-methyltransferase (None).